Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Infection by closely related HIV strains possible

28.11.2002


A report of an individual infected with a second strain of HIV despite effective drug treatment following the first infection has researchers concerned.



"For the first time, we’ve shown it is possible for an individual to become infected with two closely related strains of HIV," says Bruce D. Walker, M.D., a grantee of the National Institute of Allergy and Infectious Diseases (NIAID) and a researcher at Massachusetts General Hospital and Harvard Medical School.

Published in this week’s issue of Nature, these findings underscore the challenges vaccine developers face in creating a broadly effective vaccine against HIV. The first HIV vaccines may not prevent infection altogether, but rather may prevent HIV from causing disease by limiting the virus’ ability to reproduce, explains Dr. Walker. This case shows that a hypothetical vaccine against one strain of HIV may not necessarily protect the vaccinee against other, closely related strains.


"The implications of superinfection for an individual with HIV/AIDS are not yet clear," says Anthony S. Fauci, M.D., NIAID’s director. "However, there is little doubt what these new data mean in terms of public health: It is imperative that safer sex be practiced during each encounter, even when both partners are HIV-infected," he adds.

The new case involves a person whose HIV infection was kept in check for many months during structured treatment interruption (STI). In STI, antiviral therapies are frequently given during the early, acute stage of infection, but halted after the immune system has had time to adapt to the virus. Often, as in this case, a patient’s immune system rebounds enough to keep HIV suppressed. "This patient’s immune response against HIV was really quite robust," says Dr. Walker. Thus, the researchers were perplexed when, after successfully suppressing HIV for close to one year, the patient’s viral load suddenly shot upwards. Despite several more attempts to interrupt therapy, the patient was unable to hold the virus to previously attained low levels.

To understand why STI stopped working for this individual, "We dissected the immune system in very fine detail," says Dr. Walker. First, he and his co-investigators examined HIV-made proteins taken from the patient at several points in time. They detected a difference between the amino acid sequence of the original infecting virus and the virus isolated after STI failed. Additional studies confirmed that the change resulted from infection by a second HIV strain well after the first infection.

The two strains differed in overall amino acid sequence by about 12 percent, "about what we’d expect for two strains in North America," notes Dr. Walker. In comparison, the sequence difference between strains of various major subtypes, or clades, of HIV is about 30 percent. Although superinfection by strains from different clades has been reported previously, this is the first published report of infection by two strains from the same clade.

The picture became still more sobering when the researchers compared only those HIV amino acid sequences targeted by the immune system. Here, the strains differed by 50 percent. Consequently, a large fraction of the immune cells that had been produced previously and that had successfully tamped down the first virus were unable to recognize and react to the second strain. "We were stunned," says Dr. Walker. "Essentially, the immune system was encountering two markedly different viruses."

The research did uncover a few bright spots, however. For instance, immune system cells called CD8+ T cells, appeared in new, strain-specific forms after the individual became infected with the second strain. This indicates an ability on the part of the CD8+ T cells to react appropriately to newly arrived HIV strains, even in conditions of chronic infection. Thus, researchers can remain cautiously optimistic that therapeutic immunization to create broader and more potent immune responses in persons with chronic HIV infection may one day be possible.


NIAID is a component of the National Institutes of Health (NIH), which is an agency of the Department of Health and Human Services. NIAID supports basic and applied research to prevent, diagnose, and treat infectious and immune-mediated illnesses, including HIV/AIDS and other sexually transmitted diseases, illness from potential agents of bioterrorism, tuberculosis, malaria, autoimmune disorders, asthma and allergies.

Reference: M Altfeld et al. HIV-1 superinfection despite broad CD8+ T-cell responses containing replication of the primary virus. Nature 240:434-39 (2002).

Anne Oplinger | EurekAlert!
Further information:
http://www.niaid.nih.gov/

More articles from Health and Medicine:

nachricht New study points the way to therapy for rare cancer that targets the young
22.11.2017 | Rockefeller University

nachricht Penn study identifies new malaria parasites in wild bonobos
21.11.2017 | University of Pennsylvania School of Medicine

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Frictional Heat Powers Hydrothermal Activity on Enceladus

Computer simulation shows how the icy moon heats water in a porous rock core

Heat from the friction of rocks caused by tidal forces could be the “engine” for the hydrothermal activity on Saturn's moon Enceladus. This presupposes that...

Im Focus: Nanoparticles help with malaria diagnosis – new rapid test in development

The WHO reports an estimated 429,000 malaria deaths each year. The disease mostly affects tropical and subtropical regions and in particular the African continent. The Fraunhofer Institute for Silicate Research ISC teamed up with the Fraunhofer Institute for Molecular Biology and Applied Ecology IME and the Institute of Tropical Medicine at the University of Tübingen for a new test method to detect malaria parasites in blood. The idea of the research project “NanoFRET” is to develop a highly sensitive and reliable rapid diagnostic test so that patient treatment can begin as early as possible.

Malaria is caused by parasites transmitted by mosquito bite. The most dangerous form of malaria is malaria tropica. Left untreated, it is fatal in most cases....

Im Focus: A “cosmic snake” reveals the structure of remote galaxies

The formation of stars in distant galaxies is still largely unexplored. For the first time, astron-omers at the University of Geneva have now been able to closely observe a star system six billion light-years away. In doing so, they are confirming earlier simulations made by the University of Zurich. One special effect is made possible by the multiple reflections of images that run through the cosmos like a snake.

Today, astronomers have a pretty accurate idea of how stars were formed in the recent cosmic past. But do these laws also apply to older galaxies? For around a...

Im Focus: Visual intelligence is not the same as IQ

Just because someone is smart and well-motivated doesn't mean he or she can learn the visual skills needed to excel at tasks like matching fingerprints, interpreting medical X-rays, keeping track of aircraft on radar displays or forensic face matching.

That is the implication of a new study which shows for the first time that there is a broad range of differences in people's visual ability and that these...

Im Focus: Novel Nano-CT device creates high-resolution 3D-X-rays of tiny velvet worm legs

Computer Tomography (CT) is a standard procedure in hospitals, but so far, the technology has not been suitable for imaging extremely small objects. In PNAS, a team from the Technical University of Munich (TUM) describes a Nano-CT device that creates three-dimensional x-ray images at resolutions up to 100 nanometers. The first test application: Together with colleagues from the University of Kassel and Helmholtz-Zentrum Geesthacht the researchers analyzed the locomotory system of a velvet worm.

During a CT analysis, the object under investigation is x-rayed and a detector measures the respective amount of radiation absorbed from various angles....

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Ecology Across Borders: International conference brings together 1,500 ecologists

15.11.2017 | Event News

Road into laboratory: Users discuss biaxial fatigue-testing for car and truck wheel

15.11.2017 | Event News

#Berlin5GWeek: The right network for Industry 4.0

30.10.2017 | Event News

 
Latest News

Underwater acoustic localization of marine mammals and vehicles

23.11.2017 | Information Technology

Enhancing the quantum sensing capabilities of diamond

23.11.2017 | Physics and Astronomy

Meadows beat out shrubs when it comes to storing carbon

23.11.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>